FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
16/08/2022
Voltar para busca
Dado oficial do USPTO
UPPLUS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
24
Atualização mais recente
16/08/2022
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
21/10/2020
Data de registro
22/02/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
22/02/2022
Última transação
22/02/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
82
Localização do titular
AU
Examinador
RIBAUDO, MICHELLE
Unidade examinadora
N80
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
APEX BIOTECH RESEARCH PTY LTD
Representantes
Katherine P. Califa Foley & Lardner LLP
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Nutritionally fortified herbal beverages for medicinal use; Nutritionally fortified medicated beverages; Nutritionally fortified medicinal beverages for medical purposes; Vitamin enriched sparkling water for medical purposes; Nutritionally fortified water for medical purposes; Vitamin enriched water for medical purposes; disinfectants for hygiene purposes; Medicated products for oral hygienemedicated toothpaste; Medicated mouthwash for oral hygiene purposes; Preparations for oral hygienemedicated toothpasteother than dentifrices; Preparations for personal hygienedisinfectants; Disinfectants for hygienic purposes; Acne treatment preparations in the form of cleansers; Acne treatment preparations in the form of creams; anti-bacterial pharmaceutical preparations; Chemical products for pharmaceutical use for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; Chemicals for pharmaceutical use for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; Pharmaceutical preparations for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; Pharmaceutical preparations for animals for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; Pharmaceutical preparations for application to the skin for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; pharmaceutical preparations for health care for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; pharmaceutical preparations for human use for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; pharmaceutical preparations for nasal use for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; pharmaceutical preparations for oral use for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; pharmaceutical preparations for personal use for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for topical use for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; pharmaceutical preparations for veterinary use for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; pharmaceutical preparations in the form of emulsions for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; pharmaceutical preparations in the form of throat lozenges and medicated lozenges; pharmaceutical preparations in the form of tablets for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; pharmaceutical products for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; pharmaceutical products derived from natural sources for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; pharmaceutical tonic preparations for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; plant extracts for pharmaceutical purposes; plant extracts for pharmaceutical use; Pharmaceutical preparations in the nature of plant extracts for pharmaceutical use; propolis for pharmaceutical purposes; Drug delivery agents in the form of tablets that facilitate the delivery of pharmaceutical preparations; medicated mouth spray; mouth sprays for medical use; Anti-inflammatory sprays for the body for medical use; sprays for use on the body namelymedicaments for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; Acne treatment sprays for use on the body; medicated mouthwashes; medicated antiseptic mouthwashes; medical mouthwashes; mouthwashes and gargles for medical purposes; mouthwashes for medical purposes; eye drops; throat lozenges for pharmaceutical purposes; medicated throat lozenges; medical toothpastes; medicated toothpaste
Publicações
Histórico de despachos e eventos da marca no USPTO.
24 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
27/07/2022
FIMP
FINAL DISPOSITION PROCESSED
27/07/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
22/05/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
22/02/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/12/2021
PUBO
PUBLISHED FOR OPPOSITION
07/12/2021
GPNX
NOTIFICATION PROCESSED BY IB
06/12/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
17/11/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
17/11/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
17/11/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/11/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/10/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/10/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/10/2021
RFNT
REFUSAL PROCESSED BY IB
25/04/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/04/2021
RFRR
REFUSAL PROCESSED BY MPU
05/04/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
29/03/2021
CNRT
NON-FINAL ACTION WRITTEN
28/03/2021
DOCK
ASSIGNED TO EXAMINER
22/03/2021
MAFR
APPLICATION FILING RECEIPT MAILED
08/12/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/12/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
26/11/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace UPPLUS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.